Trials / Terminated
TerminatedNCT01028937
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- NTK Enterprises, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this U.S. Clinical Trial on treatment of sighted eyes is to investigate the safety and effectiveness of optimal keratoplasty (Opti-K™) treatments for hyperopia correction using the NTK Enterprises (NTK) Opti-K System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optimal Keratoplasty | Laser treatment in 16 spots at treatment energy densities up to 48 mJ per spot |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2009-12-09
- Last updated
- 2019-05-09
- Results posted
- 2019-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01028937. Inclusion in this directory is not an endorsement.